Literature DB >> 23950105

Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model.

Yi-No Wu1,2,3, Chien-Chih Wu4,5, Ming-Thau Sheu3, Kuo-Chiang Chen1,2,6, Hsiu-O Ho3, Han-Sun Chiang7,8.   

Abstract

Platelet-rich plasma (PRP) containing autologous growth factors is applied in regenerative medicine, but the lack of an optimized PRP preparation protocol causes unstable therapeutic effects. The aim of this study was to optimize the PRP preparation method and compare the effects of PRP from different preparation methods in restoration of erectile function in a rat model. The in vivo experiments used Sprague-Dawley male rats (n = 24), which were randomly divided into four groups of equal numbers: group I underwent sham operation, while the remaining three groups underwent bilateral CN crush. Crush injury groups were treated at the time of injury with an application of general PRP, optimized PRP [with the largest amount of platelet-derived growth factor (PDGF)-AB] or normal saline-only injection in the corpus cavernosum, respectively. Four weeks later, erectile function was assessed by CN electrosimulation, and penile tissue was collected for histology. Results demonstrated that in the PRP group prepared with the ACD-A anticoagulant, chitosan and incubated at -20°C for 15 days had the largest amount of PDGF-AB and showed a synergistic effect on release (p < 0.05). Functional outcome measurement and immunofluorescence staining for the dorsal nerve revealed that improvement after bilateral CN injury occurred in the optimized PRP group (p < 0.05). It was concluded that optimized PRP with a high level of growth factors was more stable, and its injection into the corpus cavernosum facilitated recovery of erectile function.
Copyright © 2013 John Wiley & Sons, Ltd. Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  activating factor; cavernous nerve; erectile dysfunction; growth factor; intracavernous pressure; platelet-rich plasma

Mesh:

Year:  2013        PMID: 23950105     DOI: 10.1002/term.1806

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  21 in total

Review 1.  Alternative Treatment for Erectile Dysfunction: a Growing Arsenal in Men's Health.

Authors:  Wade Muncey; Nicholas Sellke; Tyler Kim; Kirtishri Mishra; Nannan Thirumavalavan; Aram Loeb
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

Review 2.  Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time?

Authors:  Michela Bonanni; Laura Rehak; Gianluca Massaro; Daniela Benedetto; Andrea Matteucci; Giulio Russo; Francesco Esperto; Massimo Federici; Alessandro Mauriello; Giuseppe Massimo Sangiorgi
Journal:  Biomedicines       Date:  2022-05-08

Review 3.  Availability of platelet-rich plasma for treatment of erectile dysfunction and associated costs and efficacy: A review of current publications and Canadian data.

Authors:  Deron Britt; Udi Blankstein; Matthew Lenardis; Alexandra Millman; Ethan Grober; Yonah Krakowsky
Journal:  Can Urol Assoc J       Date:  2021-06       Impact factor: 1.862

Review 4.  Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Authors:  James L Liu; Kevin Y Chu; Andrew T Gabrielson; Run Wang; Landon Trost; Gregory Broderick; Kelvin Davies; Gerald Brock; John Mulhall; Ranjith Ramasamy; Trinity J Bivalacqua
Journal:  Sex Med       Date:  2021-05-14       Impact factor: 2.491

5.  Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage.

Authors:  Leah A Garcia; Su M Hlaing; Richard A Gutierrez; Maria D Sanchez; Istvan Kovanecz; Jorge N Artaza; Monica G Ferrini
Journal:  Int J Mol Sci       Date:  2014-09-26       Impact factor: 5.923

6.  Letter to the editor: Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.

Authors:  Eleftherios Spartalis; Diamantis I Tsilimigras; Stavros Sfoungaristos
Journal:  Investig Clin Urol       Date:  2018-06-15

Review 7.  Revisiting the Regenerative Therapeutic Advances Towards Erectile Dysfunction.

Authors:  Ming-Che Liu; Meng-Lin Chang; Ya-Chun Wang; Wei-Hung Chen; Chien-Chih Wu; Shauh-Der Yeh
Journal:  Cells       Date:  2020-05-19       Impact factor: 6.600

8.  Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.

Authors:  Ethan L Matz; Amy M Pearlman; Ryan P Terlecki
Journal:  Investig Clin Urol       Date:  2017-12-21

9.  nNOS-positive minor-branches of the dorsal penile nerves is associated with erectile function in the bilateral cavernous injury model of rats.

Authors:  Yen-Lin Chen; Ting-Ting Chao; Yi-No Wu; Meng-Chuan Chen; Ying-Hung Lin; Chun-Hou Liao; Chien-Chih Wu; Kuo-Chiang Chen; Shang-Shing P Chou; Han-Sun Chiang
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

10.  Therapeutic Effect of Platelet-Rich Plasma in Rat Spinal Cord Injuries.

Authors:  Nan-Fu Chen; Chun-Sung Sung; Zhi-Hong Wen; Chun-Hong Chen; Chien-Wei Feng; Han-Chun Hung; San-Nan Yang; Kuan-Hao Tsui; Wu-Fu Chen
Journal:  Front Neurosci       Date:  2018-04-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.